Trial Profile
OLYMPIA
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2008
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms OLYMPIA
- 17 Oct 2008 One-year results presented at the Cardiovascular Research Foundation's Transcatheter Cardiovascular Therapeutics symposium.
- 02 Sep 2008 One-year results presented at the European Society of Cardiology 2008.
- 14 May 2007 Enrolment in the European and Intercontinental phases completed.